デジタル糖尿病管理の市場規模、シェア、動向分析レポート：製品タイプ別、最終用途別、地域別、セグメント別予測、2025年～2030年

デジタル糖尿病管理市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界のデジタル糖尿病管理市場規模は、2025～2030年にかけてCAGR 8.7％を記録し、2030年までに219億米ドルに達する見込みです。

市場成長の主要要因は、世界の糖尿病罹患率の増加、製品発売数の増加、予測分析や人工知能（AI）などの技術革新です。

データ分析と人工知能は、今や糖尿病患者向けのデジタルソリューションに不可欠な要素となっています。AIは、大量の患者情報を活用できることから、急速に注目を集めています。デジタル糖尿病管理ツールは、患者のグルコースレベルとパターンの分析を支援します。また、患者が食事摂取量やインスリン投与量を決定するのにも役立ちます。疾病管理用のスマートフォンアプリの数はここ数年で飛躍的に増加しており、市場を大きく後押ししています。例えば、2019年9月、AbbottはSanofiと非独占的パートナーシップを締結し、クラウド接続型インスリンペン（Sanofi）とFreeStyle Libreモバイルアプリケーション（Abbott）を統合し、糖尿病の管理プロセスを容易にしました。

市場の成長は、肥満の有病率の増加、高齢化人口の増加、糖尿病予防医療に関する意識の高まりによってさらに促進されます。さらに、スマートデバイスのアクティブユーザー数の増加や、患者が血糖値をモニターできる新しいアプリの発売が市場を牽引しています。これらのアプリは、医療専門家のために先進的技術を使用し、患者により良い健康結果を記載しています。2019年5月、Roche Diabetes Care Indiaは、Accu-Chek Instant血糖モニタリング（BGM）システムとMy Sugarアプリの発売により、インドにおける統合糖尿病管理ソリューション（IDMS）プログラムを導入しました。この組み合わせは、次世代BGMシステムの登場を意味します。これにより、同製品の需要が促進され、同国の市場全体が牽引されることが期待されます。

デジタル糖尿病管理市場レポートハイライト

• 持続血糖モニタリングシステムセグメントが2024年に40.4%のシェアを獲得し、市場を独占しました。CGMシステムはリアルタイムのグルコース追跡を提供し、1型糖尿病と2型糖尿病の両方の管理に重要な洞察を記載しています。
• ウェアラブルデバイスセグメントは、2024年に最大の市場シェアを占め、また、利便性、継続的モニタリング、リアルタイムデータ追跡に対する需要の高まりによって、予測期間中に8.9％のCAGRで最速の成長が見込まれています。
• 病院セグメントは2024年に41.5%のシェアを獲得し、市場を独占しました。病院は、重症または複雑な糖尿病患者の診断検査、先進的治療、モニタリングの主要な舞台であり続けています。
• 北米のデジタル糖尿病管理市場は、2024年に38.2％の最大シェアを占めました。この優位性は、同地域における大手市場参入企業の存在と、糖尿病有病率の増加によるものです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 デジタル糖尿病管理市場の変数、動向、範囲

• 市場系統の展望
  • 親市場の展望
  • 関連/付随市場の展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• デジタル糖尿病管理市場分析ツール
  • 産業分析-ポーターのファイブフォース分析
  • PESTEL分析

第4章 デジタル糖尿病管理市場：製品別、推定・動向分析

• セグメントダッシュボード
• 世界のデジタル糖尿病管理の製品市場変動分析
• 世界のデジタル糖尿病管理市場規模と動向分析、製品別、2018～2030年
• スマート血糖値測定器
• 持続血糖モニタリングシステム
• スマートインスリンペン
• スマートインスリンポンプ/クローズドループシステム
• アプリ

第5章 デジタル糖尿病管理市場：タイプ別、推定・動向分析

• セグメントダッシュボード
• 世界のデジタル糖尿病管理のタイプ市場変動分析
• 世界のデジタル糖尿病管理市場規模と動向分析、タイプ別、2018～2030年
• ウェアラブルデバイス
• ハンドヘルドデバイス

第6章 デジタル糖尿病管理市場：最終用途別、推定・動向分析

• セグメントダッシュボード
• 世界のデジタル糖尿病管理の最終用途市場変動分析
• 世界のデジタル糖尿病管理市場規模と動向分析、最終用途別、2018～2030年
• 病院
• 在宅医療
• 診断センター

第7章 デジタル糖尿病管理市場：製品、タイプ、最終用途による地域別、推定・動向分析

• 地域別市場シェア分析、2024年と2030年
• 地域別市場ダッシュボード
• 世界地域市場のスナップショット
• 市場規模、予測動向分析、2018～2030年
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業/競合の分類
• 主要企業の市場シェア分析、2024年
• Company Position Analysis
• 企業分類（新興企業、イノベーター、リーダー）
• 企業プロファイル
  • Abbott
  • Medtronic
  • F. Hoffmann-La Roche Ltd.
  • Bayer AG
  • LifeScan, Inc.
  • Dexcom, Inc.
  • Sanofi
  • Insulet Corporation
  • Ascensia Diabetes Care Holdings AG
  • B. Braun Melsungen AG

List of Tables

• Table 1. List of secondary sources
• Table 2. List of abbreviation
• Table 3. North America digital diabetes management market, By country, 2018 - 2030 (USD Million)
• Table 4. North America digital diabetes management market, By product, 2018 - 2030 (USD Million)
• Table 5. North America digital diabetes management market, By type, 2018 - 2030 (USD Million)
• Table 6. North America digital diabetes management market, By end-use, 2018 - 2030 (USD Million)
• Table 7. U.S. digital diabetes management market, By product, 2018 - 2030 (USD Million)
• Table 8. U.S. digital diabetes management market, By type, 2018 - 2030 (USD Million)
• Table 9. U.S. digital diabetes management market, By end-use, 2018 - 2030 (USD Million)
• Table 10. Canada digital diabetes management market, By product, 2018 - 2030 (USD Million)
• Table 11. Canada digital diabetes management market, By type, 2018 - 2030 (USD Million)
• Table 12. Canada digital diabetes management market, By end-use, 2018 - 2030 (USD Million)
• Table 13. Mexico digital diabetes management market, By product, 2018 - 2030 (USD Million)
• Table 14. Mexico digital diabetes management market, By type, 2018 - 2030 (USD Million)
• Table 15. Mexico digital diabetes management market, By end-use, 2018 - 2030 (USD Million)
• Table 16. Europe digital diabetes management market, By country, 2018 - 2030 (USD Million)
• Table 17. Europe digital diabetes management market, By product, 2018 - 2030 (USD Million)
• Table 18. Europe digital diabetes management market, By type, 2018 - 2030 (USD Million)
• Table 19. Europe digital diabetes management market, By end-use, 2018 - 2030 (USD Million)
• Table 20. UK digital diabetes management market, By product, 2018 - 2030 (USD Million)
• Table 21. UK digital diabetes management market, By type, 2018 - 2030 (USD Million)
• Table 22. UK digital diabetes management market, By end-use, 2018 - 2030 (USD Million)
• Table 23. Germany digital diabetes management market, By product, 2018 - 2030 (USD Million)
• Table 24. Germany digital diabetes management market, By type, 2018 - 2030 (USD Million)
• Table 25. Germany digital diabetes management market, By end-use, 2018 - 2030 (USD Million)
• Table 26. France digital diabetes management market, By product, 2018 - 2030 (USD Million)
• Table 27. France digital diabetes management market, By type, 2018 - 2030 (USD Million)
• Table 28. France digital diabetes management market, By end-use, 2018 - 2030 (USD Million)
• Table 29. Italy digital diabetes management market, By product, 2018 - 2030 (USD Million)
• Table 30. Italy digital diabetes management market, By type, 2018 - 2030 (USD Million)
• Table 31. Italy digital diabetes management market, By end-use, 2018 - 2030 (USD Million)
• Table 32. Denmark digital diabetes management market, By product, 2018 - 2030 (USD Million)
• Table 33. Denmark digital diabetes management market, By type, 2018 - 2030 (USD Million)
• Table 34. Denmark digital diabetes management market, By end-use, 2018 - 2030 (USD Million)
• Table 35. Sweden digital diabetes management market, By product, 2018 - 2030 (USD Million)
• Table 36. Sweden digital diabetes management market, By type, 2018 - 2030 (USD Million)
• Table 37. Sweden digital diabetes management market, By end-use, 2018 - 2030 (USD Million)
• Table 38. Norway digital diabetes management market, By product, 2018 - 2030 (USD Million)
• Table 39. Norway digital diabetes management market, By type, 2018 - 2030 (USD Million)
• Table 40. Norway digital diabetes management market, By end-use, 2018 - 2030 (USD Million)
• Table 41. Asia Pacific digital diabetes management market, By country, 2018 - 2030 (USD Million)
• Table 42. Asia Pacific digital diabetes management market, By product, 2018 - 2030 (USD Million)
• Table 43. Asia Pacific digital diabetes management market, By type, 2018 - 2030 (USD Million)
• Table 44. Asia Pacific digital diabetes management market, By end-use, 2018 - 2030 (USD Million)
• Table 45. Japan digital diabetes management market, By product, 2018 - 2030 (USD Million)
• Table 46. Japan digital diabetes management market, By type, 2018 - 2030 (USD Million)
• Table 47. Japan digital diabetes management market, By end-use, 2018 - 2030 (USD Million)
• Table 48. China digital diabetes management market, By product, 2018 - 2030 (USD Million)
• Table 49. China digital diabetes management market, By type, 2018 - 2030 (USD Million)
• Table 50. China digital diabetes management market, By end-use, 2018 - 2030 (USD Million)
• Table 51. India digital diabetes management market, By product, 2018 - 2030 (USD Million)
• Table 52. India digital diabetes management market, By type, 2018 - 2030 (USD Million)
• Table 53. India digital diabetes management market, By end-use, 2018 - 2030 (USD Million)
• Table 54. Australia digital diabetes management market, By product, 2018 - 2030 (USD Million)
• Table 55. Australia digital diabetes management market, By type, 2018 - 2030 (USD Million)
• Table 56. Australia digital diabetes management market, By end-use, 2018 - 2030 (USD Million)
• Table 57. South Korea digital diabetes management market, By product, 2018 - 2030 (USD Million)
• Table 58. South Korea digital diabetes management market, By type, 2018 - 2030 (USD Million)
• Table 59. South Korea digital diabetes management market, By end-use, 2018 - 2030 (USD Million)
• Table 60. Thailand digital diabetes management market, By product, 2018 - 2030 (USD Million)
• Table 61. Thailand digital diabetes management market, By type, 2018 - 2030 (USD Million)
• Table 62. Thailand digital diabetes management market, By end-use, 2018 - 2030 (USD Million)
• Table 63. Latin America digital diabetes management market, By Country, 2018 - 2030 (USD Million)
• Table 64. Latin America digital diabetes management market, By product, 2018 - 2030 (USD Million)
• Table 65. Latin America digital diabetes management market, By type, 2018 - 2030 (USD Million)
• Table 66. Latin America digital diabetes management market, By end-use, 2018 - 2030 (USD Million)
• Table 67. Brazil digital diabetes management market, By product, 2018 - 2030 (USD Million)
• Table 68. Brazil digital diabetes management market, By type, 2018 - 2030 (USD Million)
• Table 69. Brazil digital diabetes management market, By end-use, 2018 - 2030 (USD Million)
• Table 70. Argentina digital diabetes management market, By product, 2018 - 2030 (USD Million)
• Table 71. Argentina digital diabetes management market, By type, 2018 - 2030 (USD Million)
• Table 72. Argentina digital diabetes management market, By end-use, 2018 - 2030 (USD Million)
• Table 73. Middle East & Africa digital diabetes management market, By country, 2018 - 2030 (USD Million)
• Table 74. Middle East & Africa digital diabetes management market, By product, 2018 - 2030 (USD Million)
• Table 75. Middle East & Africa digital diabetes management market, By type, 2018 - 2030 (USD Million)
• Table 76. Middle East & Africa digital diabetes management market, By end-use, 2018 - 2030 (USD Million)
• Table 77. South Africa digital diabetes management market, By product, 2018 - 2030 (USD Million)
• Table 78. South Africa digital diabetes management market, By type, 2018 - 2030 (USD Million)
• Table 79. South Africa digital diabetes management market, By end-use, 2018 - 2030 (USD Million)
• Table 80. Saudi Arabia digital diabetes management market, By product, 2018 - 2030 (USD Million)
• Table 81. Saudi Arabia digital diabetes management market, By type, 2018 - 2030 (USD Million)
• Table 82. Saudi Arabia digital diabetes management market, By end-use, 2018 - 2030 (USD Million)
• Table 83. UAE digital diabetes management market, By product, 2018 - 2030 (USD Million)
• Table 84. UAE digital diabetes management market, By type, 2018 - 2030 (USD Million)
• Table 85. UAE digital diabetes management market, By end-use, 2018 - 2030 (USD Million)
• Table 86. Kuwait digital diabetes management market, By product, 2018 - 2030 (USD Million)
• Table 87. Kuwait digital diabetes management market, By type, 2018 - 2030 (USD Million)
• Table 88. Kuwait digital diabetes management market, By end-use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Primary interviews in North America
• Fig. 5 Primary interviews in Europe
• Fig. 6 Primary interviews in APAC
• Fig. 7 Primary interviews in Latin America
• Fig. 8 Primary interviews in MEA
• Fig. 9 Market research approaches
• Fig. 10 Value-chain-based sizing & forecasting
• Fig. 11 QFD modeling for market share assessment
• Fig. 12 Market formulation & validation
• Fig. 13 Digital diabetes management market: market outlook
• Fig. 14 Parent market outlook
• Fig. 15 Related/ancillary market outlook
• Fig. 16 Penetration and growth prospect mapping
• Fig. 17 Industry value chain analysis
• Fig. 18 Digital diabetes management market driver impact
• Fig. 19 Digital diabetes management market restraint impact
• Fig. 20 Digital diabetes management market: Product movement analysis
• Fig. 21 Digital diabetes management market: Product outlook and key takeaways
• Fig. 22 Smart glucose meters market estimates and forecast, 2018 - 2030
• Fig. 23 Continuous glucose monitoring systems market estimates and forecast, 2018 - 2030
• Fig. 24 Smart insulin pens market estimates and forecast, 2018 - 2030
• Fig. 25 Smart insulin pumps/closed loop systems market estimates and forecast, 2018 - 2030
• Fig. 26 Apps market estimates and forecast, 2018 - 2030
• Fig. 27 Digital diabetes management apps market estimates and forecast, 2018 - 2030
• Fig. 28 Weight & diet management apps market estimates and forecast, 2018 - 2030
• Fig. 29 Digital diabetes management market: End-use movement analysis
• Fig. 30 Digital diabetes management market: End-use outlook and key takeaways
• Fig. 31 Hospitals market estimates and forecast, 2018 - 2030
• Fig. 32 Home settings market estimates and forecast, 2018 - 2030
• Fig. 33 Diagnostic centers market estimates and forecast, 2018 - 2030
• Fig. 34 Global digital diabetes management market: Regional movement analysis
• Fig. 35 Global digital diabetes management market: Regional outlook and key takeaways
• Fig. 36 North America
• Fig. 37 North America market estimates and forecasts, 2018 - 2030
• Fig. 38 U.S.
• Fig. 39 U.S. market estimates and forecasts, 2018 - 2030
• Fig. 40 Canada
• Fig. 41 Canada market estimates and forecasts, 2018 - 2030
• Fig. 42 Mexico
• Fig. 43 Mexico market estimates and forecasts, 2018 - 2030
• Fig. 44 Europe
• Fig. 45 Europe market estimates and forecasts, 2018 - 2030
• Fig. 46 UK
• Fig. 47 UK market estimates and forecasts, 2018 - 2030
• Fig. 48 Germany
• Fig. 49 Germany market estimates and forecasts, 2018 - 2030
• Fig. 50 France
• Fig. 51 France market estimates and forecasts, 2018 - 2030
• Fig. 52 Italy
• Fig. 53 Italy market estimates and forecasts, 2018 - 2030
• Fig. 54 Spain
• Fig. 55 Spain market estimates and forecasts, 2018 - 2030
• Fig. 56 Denmark
• Fig. 57 Denmark market estimates and forecasts, 2018 - 2030
• Fig. 58 Sweden
• Fig. 59 Sweden market estimates and forecasts, 2018 - 2030
• Fig. 60 Norway
• Fig. 61 Norway market estimates and forecasts, 2018 - 2030
• Fig. 62 Asia Pacific
• Fig. 63 Asia Pacific market estimates and forecasts, 2018 - 2030
• Fig. 64 China
• Fig. 65 China market estimates and forecasts, 2018 - 2030
• Fig. 66 Japan
• Fig. 67 Japan market estimates and forecasts, 2018 - 2030
• Fig. 68 India
• Fig. 69 India market estimates and forecasts, 2018 - 2030
• Fig. 70 Thailand
• Fig. 71 Thailand market estimates and forecasts, 2018 - 2030
• Fig. 72 South Korea
• Fig. 73 South Korea market estimates and forecasts, 2018 - 2030
• Fig. 74 Australia
• Fig. 75 Australia market estimates and forecasts, 2018 - 2030
• Fig. 76 Latin America
• Fig. 77 Latin America market estimates and forecasts, 2018 - 2030
• Fig. 78 Brazil
• Fig. 79 Brazil market estimates and forecasts, 2018 - 2030
• Fig. 80 Argentina
• Fig. 81 Argentina market estimates and forecasts, 2018 - 2030
• Fig. 82 Middle East and Africa
• Fig. 83 Middle East and Africa market estimates and forecasts, 2018 - 2030
• Fig. 84 South Africa
• Fig. 85 South Africa market estimates and forecasts, 2018 - 2030
• Fig. 86 Saudi Arabia
• Fig. 87 Saudi Arabia market estimates and forecasts, 2018 - 2030
• Fig. 88 UAE
• Fig. 89 UAE market estimates and forecasts, 2018 - 2030
• Fig. 90 Kuwait
• Fig. 91 Kuwait market estimates and forecasts, 2018 - 2030
• Fig. 92 Market share of key market players- Digital diabetes management market

Digital Diabetes Management Market Growth & Trends:

The global digital diabetes management market size is expected to reach USD 21.9 billion by 2030, registering a CAGR of 8.7% from 2025 to 2030, according to a new report by Grand View Research, Inc. Major factors contributing to the market growth are the growing incidences of diabetes globally, the increasing number of product launches, and innovation in technologies such as predictive analytics and artificial intelligence (AI).

Data analytics and artificial intelligence are now an integral part of digital solutions for diabetics. AI is gaining rapid attention due to its ability to harness massive volumes of patient information. Digital diabetes management tools help patients analyze their glucose levels and pattern. They also help patients decide on food intake and dosage of insulin. The number of smartphone apps for disease management has seen a monumental rise over the past few years, giving the market a major boost. For instance, in September 2019, Abbott entered into a non-exclusive partnership with Sanofi to integrate cloud-connected insulin pens (Sanofi) with FreeStyle Libre mobile application (Abbott) to ease the management process of diabetes.

The market growth is further augmented by the increasing prevalence of obesity, the growing aging population, and increasing awareness regarding diabetes preventive care. Moreover, the market is driven by the increasing number of active users of smart devices and the launch of new apps that allow patients to monitor their blood glucose. These apps use advanced technology for health care professionals and provide patients with better health outcomes. In May 2019, Roche Diabetes Care India introduced its Integrated Diabetes Management Solution (IDMS) program in India with the launch of the Accu-Chek Instant blood glucose monitoring (BGM) system and the My Sugar app. The combination marks the entry of the next-generation BGM system. This is expected to propel the demand for the product, thereby driving the overall market in the country.

Digital Diabetes Management Market Report Highlights:

• The continuous glucose monitoring systems segment dominated the market by capturing a share of 40.4% in 2024. CGM systems offer real-time glucose tracking, providing critical insights for both Type 1 and Type 2 diabetes management.
• The wearable devices segment held the largest market share in 2024 and is also expected to grow at the fastest CAGR of 8.9% over the forecast period, driven by the increasing demand for convenience, continuous monitoring, and real-time data tracking.
• The hospital segment dominated the market by capturing a share of 41.5% in 2024. Hospitals remain the primary setting for diagnostic testing, advanced treatments, and monitoring for patients with severe or complex diabetes.
• North America digital diabetes management market held the largest share of 38.2% in 2024. This dominance is driven by the presence of leading market players in the region and the increasing prevalence of diabetes.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Type
  • 1.2.3. End Use
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Type outlook
  • 2.2.3. End Use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Digital Diabetes Management Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing prevalence of diabetes
    • 3.2.1.2. Growing use of wearable devices for glucose monitoring
    • 3.2.1.3. Increasing awareness about diabetes management
    • 3.2.1.4. Supportive government initiatives and reimbursement policies
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High costs associated with digital diabetes management devices and technologies
    • 3.2.2.2. Limited access to digital healthcare infrastructure in developing regions
• 3.3. Digital Diabetes Management Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Digital Diabetes Management Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Digital Diabetes Management Product Market Movement Analysis
• 4.3. Global Digital Diabetes Management Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Smart Glucose Meters
  • 4.4.1. Smart glucose meters market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Continuous Glucose Monitoring Systems
  • 4.5.1. Continuous glucose monitoring systems market estimates and forecasts 2018 to 2030 (USD Million)
• 4.6. Smart Insulin Pens
  • 4.6.1. Smart insulin pens market estimates and forecasts 2018 to 2030 (USD Million)
• 4.7. Smart Insulin Pumps/Closed Loop Systems
  • 4.7.1. Smart insulin pumps/closed loop systems market estimates and forecasts 2018 to 2030 (USD Million)
• 4.8. Apps
  • 4.8.1. Apps market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.8.1.1. Digital diabetes management apps
      • 4.8.1.1.1. Digital diabetes management apps market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.8.1.2. Weight & diet management apps
      • 4.8.1.2.1. Weight & diet management apps market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Digital Diabetes Management Market: Type Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Digital Diabetes Management Type Market Movement Analysis
• 5.3. Global Digital Diabetes Management Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
• 5.4. Wearable Devices
  • 5.4.1. Wearable devices market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Handheld Devices
  • 5.5.1. Handheld devices market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Digital Diabetes Management Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Digital Diabetes Management End Use Market Movement Analysis
• 6.3. Global Digital Diabetes Management Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 6.4. Hospitals
  • 6.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Home Settings
  • 6.5.1. Research institutes market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Diagnostic Centers
  • 6.6.1. Diagnostic centers market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Digital Diabetes Management Market: Regional Estimates & Trend Analysis By Product, Type, End Use

• 7.1. Regional Market Share Analysis, 2024 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Global Regional Market Snapshot
• 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.5. North America
  • 7.5.1. U.S.
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Competitive scenario
    • 7.5.1.3. Regulatory framework
    • 7.5.1.4. Reimbursement structure
    • 7.5.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.2. Canada
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Competitive scenario
    • 7.5.2.3. Regulatory framework
    • 7.5.2.4. Reimbursement structure
    • 7.5.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.3. Mexico
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Competitive scenario
    • 7.5.3.3. Regulatory framework
    • 7.5.3.4. Reimbursement structure
    • 7.5.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Europe
  • 7.6.1. UK
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Competitive scenario
    • 7.6.1.3. Regulatory framework
    • 7.6.1.4. Reimbursement structure
    • 7.6.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.2. Germany
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Competitive scenario
    • 7.6.2.3. Regulatory framework
    • 7.6.2.4. Reimbursement structure
    • 7.6.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.3. France
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Competitive scenario
    • 7.6.3.3. Regulatory framework
    • 7.6.3.4. Reimbursement structure
    • 7.6.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.4. Italy
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Competitive scenario
    • 7.6.4.3. Regulatory framework
    • 7.6.4.4. Reimbursement structure
    • 7.6.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.5. Spain
    • 7.6.5.1. Key country dynamics
    • 7.6.5.2. Competitive scenario
    • 7.6.5.3. Regulatory framework
    • 7.6.5.4. Reimbursement structure
    • 7.6.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.6. Norway
    • 7.6.6.1. Key country dynamics
    • 7.6.6.2. Competitive scenario
    • 7.6.6.3. Regulatory framework
    • 7.6.6.4. Reimbursement structure
    • 7.6.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.7. Sweden
    • 7.6.7.1. Key country dynamics
    • 7.6.7.2. Competitive scenario
    • 7.6.7.3. Regulatory framework
    • 7.6.7.4. Reimbursement structure
    • 7.6.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.8. Denmark
    • 7.6.8.1. Key country dynamics
    • 7.6.8.2. Competitive scenario
    • 7.6.8.3. Regulatory framework
    • 7.6.8.4. Reimbursement structure
    • 7.6.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. Asia Pacific
  • 7.7.1. Japan
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Competitive scenario
    • 7.7.1.3. Regulatory framework
    • 7.7.1.4. Reimbursement structure
    • 7.7.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.2. China
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Competitive scenario
    • 7.7.2.3. Regulatory framework
    • 7.7.2.4. Reimbursement structure
    • 7.7.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.3. India
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Competitive scenario
    • 7.7.3.3. Regulatory framework
    • 7.7.3.4. Reimbursement structure
    • 7.7.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.4. Australia
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Competitive scenario
    • 7.7.4.3. Regulatory framework
    • 7.7.4.4. Reimbursement structure
    • 7.7.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.5. South Korea
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Competitive scenario
    • 7.7.5.3. Regulatory framework
    • 7.7.5.4. Reimbursement structure
    • 7.7.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.6. Thailand
    • 7.7.6.1. Key country dynamics
    • 7.7.6.2. Competitive scenario
    • 7.7.6.3. Regulatory framework
    • 7.7.6.4. Reimbursement structure
    • 7.7.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 7.8. Latin America
  • 7.8.1. Brazil
    • 7.8.1.1. Key country dynamics
    • 7.8.1.2. Competitive scenario
    • 7.8.1.3. Regulatory framework
    • 7.8.1.4. Reimbursement structure
    • 7.8.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8.2. Argentina
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Competitive scenario
    • 7.8.2.3. Regulatory framework
    • 7.8.2.4. Reimbursement structure
    • 7.8.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 7.9. MEA
  • 7.9.1. South Africa
    • 7.9.1.1. Key country dynamics
    • 7.9.1.2. Competitive scenario
    • 7.9.1.3. Regulatory framework
    • 7.9.1.4. Reimbursement structure
    • 7.9.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9.2. Saudi Arabia
    • 7.9.2.1. Key country dynamics
    • 7.9.2.2. Competitive scenario
    • 7.9.2.3. Regulatory framework
    • 7.9.2.4. Reimbursement structure
    • 7.9.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9.3. UAE
    • 7.9.3.1. Key country dynamics
    • 7.9.3.2. Competitive scenario
    • 7.9.3.3. Regulatory framework
    • 7.9.3.4. Reimbursement structure
    • 7.9.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9.4. Kuwait
    • 7.9.4.1. Key country dynamics
    • 7.9.4.2. Competitive scenario
    • 7.9.4.3. Regulatory framework
    • 7.9.4.4. Reimbursement structure
    • 7.9.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
• 8.3. Key company market share analysis, 2024
• 8.4. Company Position Analysis
• 8.5. Company Categorization (Emerging Players, Innovators and Leaders
• 8.6. Company Profiles
  • 8.6.1. Abbott
    • 8.6.1.1. Company overview
    • 8.6.1.2. Financial performance
    • 8.6.1.3. Product benchmarking
    • 8.6.1.4. Strategic initiatives
  • 8.6.2. Medtronic
    • 8.6.2.1. Company overview
    • 8.6.2.2. Financial performance
    • 8.6.2.3. Product benchmarking
    • 8.6.2.4. Strategic initiatives
  • 8.6.3. F. Hoffmann-La Roche Ltd.
    • 8.6.3.1. Company overview
    • 8.6.3.2. Financial performance
    • 8.6.3.3. Product benchmarking
    • 8.6.3.4. Strategic initiatives
  • 8.6.4. Bayer AG
    • 8.6.4.1. Company overview
    • 8.6.4.2. Financial performance
    • 8.6.4.3. Product benchmarking
    • 8.6.4.4. Strategic initiatives
  • 8.6.5. LifeScan, Inc.
    • 8.6.5.1. Company overview
    • 8.6.5.2. Financial performance
    • 8.6.5.3. Product benchmarking
    • 8.6.5.4. Strategic initiatives
  • 8.6.6. Dexcom, Inc.
    • 8.6.6.1. Company overview
    • 8.6.6.2. Financial performance
    • 8.6.6.3. Product benchmarking
    • 8.6.6.4. Strategic initiatives
  • 8.6.7. Sanofi
    • 8.6.7.1. Company overview
    • 8.6.7.2. Financial performance
    • 8.6.7.3. Product benchmarking
    • 8.6.7.4. Strategic initiatives
  • 8.6.8. Insulet Corporation
    • 8.6.8.1. Company overview
    • 8.6.8.2. Financial performance
    • 8.6.8.3. Product benchmarking
    • 8.6.8.4. Strategic initiatives
  • 8.6.9. Ascensia Diabetes Care Holdings AG
    • 8.6.9.1. Company overview
    • 8.6.9.2. Financial performance
    • 8.6.9.3. Product benchmarking
    • 8.6.9.4. Strategic initiatives
  • 8.6.10. B. Braun Melsungen AG
    • 8.6.10.1. Company overview
    • 8.6.10.2. Financial performance
    • 8.6.10.3. Product benchmarking
    • 8.6.10.4. Strategic initiatives